| Health / Medical Topics |
MEK Inhibitor AZD8330
An orally active, selective MEK inhibitor with potential antineoplastic activity. MEK inhibitor AZD8330 specifically inhibits mitogen-activated protein kinase kinase 1 (MEK or MAP/ERK kinase1), resulting in inhibition of growth factor-mediated cell signaling and tumor cell proliferation. MEK is a key component of the RAS/RAF/MEK/ERK signaling pathway that regulates cell growth; constitutive activation of this pathway has been implicated in many cancers. (NCI Thesaurus)
YOU MAY ALSO LIKE
A substance being studied in the treatment of several types of cancer. MEK inhibitor AZD6244 blocks proteins needed for cell growth and…
An orally bioavailable small-molecule inhibitor of mitogen-activated protein kinase kinase (MAP2K, MAPK/ERK kinase, or MEK) 1 and 2 with potential antineoplastic…
One of numerous oval bodies found in the papillae of the skin, especially those of the fingers and toes; they consist of…
Human MEIS2 wild-type allele is located in the vicinity of 15q14 and is approximately 212 kb in length. This allele, which encodes…
This gene is involved in the regulation gene expression.
Human MEIS1 wild-type allele is located within 2p14-p13 and is approximately 137 kb in length. This allele, which encodes homeobox protein Meis1,…
